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Is PEPFAR Funding for Key Populations 
Aligned with the Epidemiologic Burden?
Introduction
Key populations (KPs)*—gay, bisexual, and other men who have sex with men (MSM); people who inject 
drugs (PWID), female sex workers (FSW); and transgender people (TG)—are at significantly higher risk 
for HIV, face a higher burden of disease, have less access to services, are frequently the target of stigma 
and discrimination, and are criminalized in many countries. Sustaining progress in fighting the epidemic will 
require focused attention and resources targeting KPs. A research team at amfAR recently evaluated the 
extent to which funds from the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) were allocated to 
programs targeting KPs in proportion to their epidemic burden. 
The epidemiological case for targeting  
key populations 
Worldwide, 40−50% of all HIV infections among adults aged 15−49 occur among key populations or 
their partners, with the proportion even higher (53−62%) in Eastern Europe and Central Asia. Even 
in generalized epidemics—as in most sub-Saharan African countries—the rate of new HIV infections 
among KPs is disproportionately high, from an estimated 10% in Uganda to 30% in Burkina Faso,  
34% in Kenya, 37% in Nigeria, 43% in Ghana, and 45% in Benin.1 
Worldwide, compared to the 
general adult population, MSM 
are 19 times more likely to be 
living with HIV. Among the 96 
countries that reported MSM 
data to UNAIDS in 2013, median 
HIV prevalence among MSM was 
3.7%. Prevalence among MSM 
varies significantly, both among 
individual countries (from <1% to 57%) and regionally, from 6% in the Caribbean, Asia, and the Pacific 
to 15% in Central and Western Africa. Among countries with significant MSM epidemics, HIV prevalence 
among young MSM (<25 years) was 4.2%, suggesting that many MSM acquire HIV at a young age.2 In 
several parts of the world, including Asia, HIV incidence among MSM is increasing.3 
Worldwide, 40–50% of all HIV infections among 
adults aged 15–49 occur among key populations 
or their partners.
* Although all major international funders designate “key populations,” their definition varies. For example, the Global Fund 
to Fight AIDS, Tuberculosis and Malaria (GF) defines KPs in a way that specifically addresses overlaps among categories, 
including male sex workers: gay, bisexual and other men who have sex with men (MSM); women, men and transgender people 
who inject drugs (PWID) and/or who are sex workers (SW); and all transgender people (TG)” (see http://www.theglobalfund.org/
en/publications/2014-07-25_Key_Populations_Action_Plan_2014-2017/, p.6). The World Health Organization (WHO) includes 
“people in prisons and other closed settings” among key populations, arguing that prisoners are particularly vulnerable to HIV 
and frequently lack access to services. 
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In 110 countries with available data, HIV prevalence among FSW is 12 times higher than among the 
general adult population; in four countries, it is more than 50 times higher.4 While HIV prevalence among 
FSW averaged 12% in low- and middle-income countries, in 16 countries in sub-Saharan Africa, it 
approached 37%.5 
PWID represent 5−10% of all people living with HIV, and injecting drug use continues to be a significant 
driver of the HIV epidemic, accounting for 30% of new HIV infections outside of sub-Saharan Africa (up to 
40% in some countries). Globally, HIV prevalence is 28 times higher among PWID than the rest of the adult 
population, an estimated average of 13.5%.6 Moreover, shifting drug use patterns have the potential to 
greatly accelerate HIV transmission, particularly when injecting drug use increases or emerges in countries 
where it was not previously established.7, 8 For example, HIV outbreaks among PWID have recently emerged 
in Tanzania, Kenya and Nigeria.9 
Two KP subpopulations merit special mention. There is a dearth of reliable data on HIV among TG, 
though recent estimates suggest that HIV prevalence among transgender women is extremely high. 
UNAIDS estimates that transgender women are 49 times more likely to acquire HIV than adults aged 
15−49 in the general population.10 In a meta-analysis pooling data from 39 studies involving 11,000 
transgender women in 15 countries, HIV prevalence was 19.1%, with little difference among low-
, middle- and high-income countries.11 Moreover, for epidemiological or other tracking purposes, 
transgender women are 
frequently grouped with MSM. 
Male sex workers are frequently 
included only as subsets of 
larger studies among MSM, or 
even FSW.12 
Key populations 
face substantial service barriers 
MSM, SW, and PWID are criminalized to some extent almost everywhere (see figure 1). According to 
UNAIDS, as of 2014, 75 countries criminalize same-sex sexual relations, with seven jurisdictions imposing 
the death penalty for convictions under such laws. Most countries (100) criminalize aspects of sex work, 
and sex workers are often vulnerable to police harassment. Drug use is almost universally criminalized (in 
some countries even drug dependence is criminalized) and 31 countries impose the death penalty for drug 
offenses. Harsh penalties are often imposed for possession of small amounts of drugs for personal use.13,14 
Transgender women often suffer profound discrimination and stigmatization, for which legal systems rarely 
offer protection or remediation.15 
Transgender women are 49 times more likely  
to acquire HIV than other adults.
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Figure 1. Number of countries with criminalization laws affecting KPs, by region
Region
SEX WORK  
(any aspect)a
MSM (same sex  
sexual activity)a
PWID  
(death penalty)a,b
Total number of  
countries in region
Asia and the Pacific 17(2) 19(0) 15(0) 38
East and Southern Africa 13(2) 15(1) 1(0) 21
Eastern Europe  
and Central Asia
19(0) 2(0) 0(0) 30
Latin America and  
the Caribbean
13(0) 11(0) 1(0) 33
North Africa and  
Middle East
19(0) 15(2) 13(0) 21
West and Central Africa 14(2) 13(0) 0(0) 24
Western and Central Europe, 
North America
5(0) 0(0) 1(0) 23
Total 100 75 31
**Value in superscript indicates number of countries with missing data. 
Source: UNAIDS AIDSinfo, 2014. 
Global HIV prevention service coverage  
among KPs is low
In most countries, HIV services coverage is lower among KPs than among the general population. For 
example, according to the World Bank: worldwide in 2010, fewer than one in ten MSM had access to basic 
HIV/AIDS prevention, care, and treatment services;16 fewer than 50% of FSW had access to basic HIV 
prevention services;17 and access to needle and syringe programs (NSP), HIV counseling and testing (HCT), 
opioid substitution therapy (OST), and antiretroviral therapy (ART) among PWID was generally low.18 
• Among 20 countries reporting to UNAIDS in 2013, average access to HIV prevention programs among 
MSM was 40%, compared to 59% in 2009.19 In a 2012 survey among 5,779 MSM in 165 countries, 
35% of participants reported having access to condoms, 21% to lubricants, 36% to HIV testing, and 
(among those living with HIV) 42% to ART, with access correlating in each instance with country 
income level.20 
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• Only one-third of countries report targeted risk-reduction programs for SW, and very few countries have 
implemented national-level SW-specific programming, primarily in Asia and sub-Saharan Africa. Many 
programs that do exist are limited in scope, providing only condoms and limited HIV testing.21 
• Availability of HIV prevention services among PWID in most countries falls below even “low” thresholds 
established by UNAIDS, though there is very substantial regional variation. In 2010, worldwide NSP 
coverage was estimated to be 12 needles per person per month; only 8% of PWID had access to OST; 
and only 4% of PWID living with HIV had access to ART.22 By 2014, in reports to UNAIDS, only 79 
of 192 countries offered OST, while only 55 provided NSPs. Countries that have implemented NSPs 
distribute an average of only 74 needles per person per year and only 18% of countries meet the target 
of 200 needles. In Southwest Asia, where HIV prevalence among PWID is higher than elsewhere in the 
world, no country reports high levels of coverage for any PWID prevention service. The 16 countries 
where 45% of the world’s PWID are estimated to live (accounting for 66% of PWID who are living with 
HIV) all have low NSP and OST coverage.23 The majority of HIV-positive PWID do not have access to 
ART; one estimate suggests that only 10% are receiving ART.24 
PEPFAR support for KP programs 
While in some ways, PEPFAR’s original authorizing legislation actually discouraged programs targeting KP 
(see text box), since its launch in 2003, PEPFAR has steadily increased its programmatic focus on KPs. 
In 2008, the PEPFAR reauthorization officially recognized the need for programs targeting “most-at-risk-
populations,” including MSM, SW and PWID. Nonetheless, PEPFAR faced considerable resistance from 
many host countries to undertaking data collection efforts or implementing programs targeting KPs.25 An 
amfAR/Johns Hopkins analysis of PEPFAR funding in 2009−2010 showed that countries with epidemics 
concentrated among MSM and PWID received proportionally less money than countries with generalized 
epidemics, after controlling for number of people living with HIV, total population, and per capita income.26 
A more recent analysis applying the same algorithm to 2010−2014 planned COP funding suggests that this 
disparity continues.27 
U.S. government policy barriers to PEPFAR KP programming
Since its launch, PEPFAR programming targeting KPs has been impeded by various Congressional restrictions:
• Organizations receiving PEPFAR funds have been required to explicitly oppose prostitution and sex trafficking (i.e., the “anti-
prostitution pledge”). In 2013, the U.S. Supreme Court ruled that requiring U.S.-based organizations to sign the anti-prostitution 
pledge was unconstitutional,28 though as of its FY16 guidance, PEPFAR continues to require non-U.S. organizations to adhere  
to the pledge.29 
• Organizations are permitted to limit the services they deliver based on their religious or moral philosophy (i.e., the  
“conscience clause”). 
• The decades-long Congressional ban on the use of federal funds for syringe exchange programs complicated U.S. funding for 
such programs internationally. Consequently, PEPFAR administrators did not allocate funds for this purpose in the program’s early 
years,30 even after the domestic ban was lifted by the Obama Administration in 2009. Following an HIV outbreak associated with 
injection drug use in Indiana, the Congressional ban was finally lifted in 2015.31
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More recently, PEPFAR has committed to increasing access to and uptake of HIV services among KPs,32 
provided technical assistance to countries for scaling up evidence-based interventions, issued guidance 
pertaining to HIV prevention interventions among MSM33 and PWID,34 and directed country teams to 
prioritize ART among KPs.35 
In 2012, PEPFAR announced a $15 million implementation research initiative to identify specific interventions 
effective among KPs, a $20 million challenge fund to support country-led KP plans, and a $2 million 
contribution to the Robert Carr Civil Society Networks Fund, which supports capacity building among KP 
networks. In 2014, USAID awarded funding for LINKAGES, a five-year initiative being implemented by FHI 
360 to reduce HIV transmission among KPs and to improve their enrollment and retention in care. In 2015 
PEPFAR partnered with the Elton John AIDS Foundation direct an additional $10 million to support programs 
focusing on Lesbian, Gay, Bisexual and Transgender people affected by HIV/AIDS. And in 2016, PEPFAR 
announced a $100 million Key Populations Investment Fund, designed to expand access to proven HIV 
prevention and treatment services for key populations.36 
In many settings, key populations are at higher risk for acquiring HIV 
but are often the least likely to obtain HIV services. Now more than 
ever, people who inject drugs, sex workers, and men who have sex 
with men face stigma and discrimination. Human rights among lesbian, 
gay, bisexual and transgender (LGBT) people in certain parts of the 
world are increasingly under threat, creating additional barriers to key 
populations accessing services. If any one of our populations is left 
behind, we are all left behind and we will not control the epidemic. 
— PEPFAR 3.0
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A primer: How does PEPFAR track its support for KP programs?
All PEPFAR-funded countries and regions report spending in two ways: planned funding and actual expenditures. 
Since its inception in 2004, PEPFAR-funded countries or regions have been required to develop Country Operational Plans (COPs) 
or Regional Operational Plans (ROPs) that describe planned activities and targets for the following fiscal year and allocate country or 
regional level budgets. In 2012, PEPFAR began conducting annual expenditure analyses (EA) that track actual expenditures.
In both COPS and EAs, PEPFAR tracks spending in a variety of ways. With COPs, all planned PEPFAR activities are allocated to specific 
budget codes and in 2009, a specific budget code (IDUP)† was designated to capture activities targeting people who use drugs. Also 
in COPS, since 2013, PEPFAR has also tracked the proportion of all planned funding by 16 cross-cutting attributes, including two key 
population attributes (MSM/TG and FSW),‡ designed to capture focus activities including: 
1) core HIV prevention interventions consistent with PEPFAR guidance; 
2) training of health workers and community outreach workers; 
3) collection and use of strategic information; 
4) epidemiologic, social science, and operational research; 
5) monitoring and evaluation; and 
6) procurement of condoms, lubricants, and other commodities. 
Conversely, EAs report actual expenditures across 17 program areas, four of which pertain to sexual and other risk prevention among 
MSM, FSW,§ PWID, and “key populations other”.
Comparing planned funding with actual expenditures is complicated, as PEPFAR funding is both continuous and dynamic. For example, 
funding plans outlined in COPs may or may not be reflected as actual expenditures in the following fiscal year, as approved funding plans 
change, or unspent funds are re-allocated to subsequent years. Comparisons are made even more difficult because the two tracking 
systems are not well-aligned, e.g., COP cross-cutting attributes do not align with EA program areas, while EAs are not reported by 
budget code. 
amfAR has compiled data from both COP and EA data sets in a publicly accessible online database (http://copsdata.amfar.org/s)
† The “IDUP Biomedical Prevention: Injecting and non-Injecting Drug Use” code is intended to capture activities including needle and syringe access programs, policy 
reform, training, message development, community mobilization and PWID networks, and medical-assisted therapies (MAT) for HIV-negative PWID or comprehensive 
drug treatment of other drug addictions, such as methamphetamine. Because budget codes are mutually exclusive, certain activities targeting PWID may be captured 
in other budget codes, including sexual or non-injection drug (e.g., alcohol) prevention programs among PWID (HVOP – other sexual prevention), MAT or continuum  
of care services for HIV-positive PWIDs (HBHC – adult care and support).
‡ The MSM/TG attribute is meant to capture activities that focus on gay men, other men who have sex with men including male sex workers, and those who do not 
conform to male gender norms and may identify as a third gender or transgender (TG).
§ Sexual and other risk prevention, commercial sex worker.
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Most program spending is initially coded by the implementing mechanism (IM), i.e., the grant, contract, 
or cooperative agreement through which funds are disbursed and reported up to the PEPFAR country team. 
Until 2013, COPs included narrative descriptions of program activities funded under each budget code, 
although they rarely changed from year to year. But in 2014, the narrative requirement was dropped, and 
countries that attributed spending to either KP cross-cutting attribute were required only to indicate (via 
check box) which of the six focus activities were funded. 
Is PEPFAR funding tracking epidemics among key 
populations?
In light of PEPFAR’s stated commitment to prioritize KP programming, a research team from amfAR, The 
Foundation for AIDS Research, undertook a study to understand the extent to which PEPFAR supports KP 
programs, how well such support aligns with KP epidemiology, and whether KP programming is consistent 
with best practices. In the study, the team compiled and analyzed both planned KP funding and actual KP 
expenditures data, as well as KP HIV surveillance data for PEPFAR-funded countries where available for 
2009−2015. 
Overall planned funding for KPs is stable, with a 
possible upward trend
To assess the ongoing evolution of PEPFAR’s commitment to supporting KP programming, the team first 
compared planned funding levels for each KP from year to year (2009−2015, as available) in terms of 
absolute total dollars, percentage of all planned HIV prevention funding, and percentage of total funding for 
each country. In figure 3, below, KP prevention funding is shown as a percentage of total funding from 2013 
to 2015 (2009−2015 for PWID).
• For MSM/TG, planned funding increased significantly (79%) between 2014 and 2015, with 60% of 
countries increasing both absolute totals and the percentage of overall planned funding. 
• For FSW, planned funding was up slightly from 2013/2014 to 2015, both in absolute dollars and as 
a percentage of planned prevention funding. But again, some countries (59%) spent more and some 
spent less (41%); dramatic increases in the Caribbean (2,161%) and Nigeria (1,190%) were offset by 
100% decreases in Vietnam, Zambia, Namibia, South Sudan, Swaziland, and Ukraine
• For PWID, total planned funding increased from 2009 to 2011, decreased in 2012, and increased in 
2013; among countries with planned funding, however, the median increased in 2010, decreased in 
2011−12, and increased in 2013−15. 
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Figure 3. KP prevention funding as a percentage of total funding, 2009−2015
(NOTE: MSM and FSW data are reported only for 2013−2015.)
Actual expenditures for KPs don’t always match 
planned funding
The team then compared actual 2014 expenditures with 2013 planned funding to assess the extent to 
which plans were carried out. In figure 4, the difference between planned funding and actual expenditures 
(comparing KP prevention funding expressed as a percentage of total COP prevention funding) is shown 
for each KP. While there is no consistent trend, in many instances actual expenditures exceeded planned 
funding, while in others they fell far short.
• For MSM/TG, almost a quarter of countries spent less in 2014 than planned in 2013.
• For FSW, some countries (a slight majority) spent more in 2014 than planned in 2013, while others 
spent less.
• For PWID, not all countries planned IDUP funding in 2013, but all countries reported actual 
expenditures on at least some WHO comprehensive PWID interventions in 2014; nonetheless, 
expressed as a percentage of total HIV prevention outlays, 2014 actual expenditures were lower (7.18%) 
than 2013 planned funding (8.61%). 
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Figure 4.
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Actual expenditures for KP programming are not 
well aligned with KP epidemiology
To illustrate whether PEPFAR KP funding aligned with HIV epidemiology, the team plotted 2014 actual 
expenditures against HIV prevalence ratios for each KP, i.e., relative risk for HIV infection compared to the 
general population. While HIV prevalence among key populations was signifi cantly higher than among the 
general population in all countries, prevalence ratios varied considerably and actual expenditures for KP 
programming were not well correlated with higher prevalence ratios. 
• Figure 5. Of the seven countries with MSM/TG HIV prevalence ratios within the top quartile, four 
(Cameroon, Democratic Republic of the Congo, Haiti, and India—shown in red), had below average 
spending for MSM/TG as a percentage of total HIV prevention expenditure. 
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• Figure 6. Among the two regions (Asia, Central Asia) and three countries (Cambodia, Myanmar, 
Indonesia) with PWID prevalence ratios in the top quartile, all but Central Asia reported lower than 
average prevention spending for PWID as a percentage of total prevention spending in 2014. 
[Indicated in red]
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It is not always clear what types of KP programs 
are funded, or whether funded programs are 
evidence-based 
Finally, beyond budget coding, PEPFAR reporting is often insuffi cient to determine which types of KP 
programs are funded, and the extent to which these programs constitute evidence-based practices. To 
better understand whether planned activities were KP-specifi c, the team reviewed COP 2013 mechanism 
narratives for relevant budget codes for which countries designated a portion of funding with FSW or MSM 
cross-cutting attributes, in each case assessing the extent to which narratives referred specifi cally to KPs. 
• Figure 7. Of the countries with the highest comparative HIV risk among FSW (PRs in the top quartile), 
three countries (Ethiopia, Rwanda, and Burundi—shown in red), reported below average expenditures 
for FSW. 
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FSW Mechanism Analysis 2013 (n=96)
Budget Code n (%) Mechanism Type n (%)
HVOP - Sexual Prevention: Other Sexual Prevention 62 (43) Non-specific (serving the general population, including 
FSW)
45 (47)
HVCT - Prevention: HIV Testing and Counseling 36 (25)
HBHC - Care: Adult Care and Support 12 (8)
KP-specific (targeting KPs, including FSW) 33 (34)
HVSI - Strategic Information 9 (6)
IDUP - Prevention: Injecting and Non-Injecting Drug 
Use
6 (4)
Non-inclusive (no mention of FSW or KPs) 17 (18)
OHSS - Health Systems Strengthening 4 (3)
MTCT - Biomedical Prevention: PMTCT 3 (2)
FSW-specific programs 1 (1)
HTXS - Treatment: Adult Treatment 3 (2)
HVAB -Sexual Prevention: Abstinence/Be Faithful 3 (2)
HVTB - Care: TB/HIV 2 (2)
HKID - Care: Orphans and Vulnerable Children 2 (2)
HLAB - Laboratory Infrastructure 2 (1)
MSM Mechanism Analysis 2013 (n=73)
Budget Code n (%) Mechanism Type n (%)
HVOP - Sexual Prevention: Other Sexual Prevention 20 (40)
KP-specific (targeting KPs, including MSM) 32 (44)
HVCT - Prevention: HIV Testing and Counseling 13 (26)
HBHC - Care: Adult Care and Support 3 (6) Non-specific (targeting the general population, including 
MSM)
22 (30)
OHSS - Health Systems Strengthening 3 (6)
HVSI - Strategic Information 3 (6)
Non-inclusive (no mention of MSM or KPs) 16 (22)
HVTB - Care: TB/HIV 2 (4)
HTXS - Treatment: Adult Treatment 2 (4)
MSM-specific programs 3 (4)
HVAB -Sexual Prevention: Abstinence/Be Faithful 2 (4)
MTCT - Biomedical Prevention: PMTCT 1 (2)
IDUP - Prevention: Injecting and Non-Injecting Drug 
Use 1 (2)
• Figure 8. The majority of mechanism narratives for MSM and FSW described programs serving the 
general population, including KPs. But KPs may be better served by targeted interventions, activities 
and outreach. 
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The team also reviewed mechanism narratives for all program activities designated with the IDUP budget 
code, to determine their nature and alignment with COP guidance by assessing whether relevant programs 
were mentioned.
• While overall IDUP funding for PWID activities fell short of need, NSPs were mentioned in only 13% 
of mechanism narratives, suggesting that one of the most effective interventions specified in WHO 
guidance is insufficiently prioritized, possibly the result of persistent U.S. government policy.
IDUP Budget Code Analysis 2013
# of mechanisms in which key program activities are mentioned, among all mechanism narratives (n=71) 
Most frequently mentioned activities: n (%)
Technical assistance, training, and capacity building 43 (60)
Medication-assisted treatment (MAT)/Opioid substitution therapy (OST) 30 (42)
Linkages and referrals 29 (41)
Least frequently mentioned activities: 
Psychosocial health & behavioral interventions for addiction 11 (15)
Policy reform around PWIDs 9 (13)
Needle and syringe exchange programs (NSP) 9 (13)
PEPFAR KP investments are substantial and 
increasing, though often inconsistent and not 
always well documented
An analysis of planned funding and actual expenditures for KP programs suggests that while both are 
increasing slightly overall, there are dramatic variations from country to country. There were examples of 
large increases (>1,000%) in KP planned funding from year to year, but also some dramatic decreases—in 
several instances to zero KP funding. Although it is difficult to interpret KP funding increases or decreases in 
a single year, it will be important to follow KP funding trends over time, as significant decreases run counter 
to the epidemiological evidence and do not represent adequate investments in the HIV response.
Actual KP expenditures don’t always match planned KP funding, though examples were not consistent. 
In some instances, countries spent less than planned, but in other instances they spent more. In some 
cases, countries reported $0 in planned KP funding, but then reported actual KP expenditures the following 
year. Because of the complexity in tracking planned funding (i.e., budget codes are not well aligned with 
expenditure analyses), additional mechanisms are needed to ensure that planned funding occurs and to 
understand discrepancies between planned funding and actual expenditures.
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Planned KP funding and actual KP expenditures were not always well correlated with HIV prevalence ratios. 
For example, some countries with very high prevalence ratios among KPs reported disproportionately 
low planned KP funding or actual KP expenditures. The relationship between reported KP expenditures 
and HIV prevalence ratios is insufficient to assess the adequacy of KP programming in any given setting. 
For example, it is possible that in hostile political environments, KP programs are undertaken discreetly 
and not appropriately coded, though it is more likely that in making funding decisions, factors other than 
epidemiology came into play. In the majority of countries, the percentage of total actual HIV prevention 
expenditures comprising KP programming is small, regardless of HIV prevalence ratios—and countries with 
low expenditures and high HIV prevalence ratios signal a mismatch in allocations.
Much PEPFAR data reporting 
was ambiguous or difficult to 
interpret, making it challenging 
to understand how funds were 
used. Moving forward, it will 
be important that PEPFAR 
tracking and reporting of KP 
programs provides a clearer 
understanding of how resources 
are allocated, and incentivizes the 
implementation and scale-up of 
evidence-based programs. 
\In particular, while it is important that interventions serving the general population do not exclude KPs, 
interventions are also needed that recognize and respond to the specific social and structural barriers KPs 
face. Among programs designated with an MSM or FSW cross-cutting attribute, a significant proportion 
of mechanism narratives neither specified how the funds would be used, nor even mentioned KPs (18% 
for FSW and 22% for MSM). Large proportions of programs designated with either attribute (47% for FSW 
and 30% for MSM) appeared to be designed for the general population including KPs, who might be better 
served by targeted programs. 
Among programs designated with the IDUP budget code (i.e., targeting PWID), NSPs were among the least 
frequently funded (mentioned in only 13% of mechanism narratives), though such programs are among the 
most effective HIV prevention interventions. Similarly, though adverse policies often constitute a significant 
barrier to services for PWID, policy reform efforts were rarely funded (13% of mechanism narratives). 
Finally, it is difficult to know the extent to which internal PEPFAR coding has been validated, raising 
questions about comparability of funding data between countries, or from year to year. Perhaps most 
critically, planned funding and expenditure analyses are themselves inconsistently reported (i.e., with 
different coding systems that do not align), making it extremely challenging to evaluate the extent to which 
funding plans are executed.
Additional mechanisms are needed to ensure 
that planned funding occurs and to understand 
discrepancies between planned funding and  
actual expenditures.
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To fulfill its stated mandate to increase access to and uptake of services among KP, PEPFAR should 
continue to strive to direct resources to targeted programming commensurate with epidemic burden, but 
also ensure that such resources support evidence-based interventions. Additionally, though PEPFAR has 
made measurable strides in the implementation of KP programs, significant policy barriers remain, including 
the anti-prostitution pledge still 
required of non-U.S. organizations, 
failure to promote lifesaving 
syringe access programs, and a 
lack of clear guidance to country 
teams regarding which harm 
reduction interventions can/cannot 
be funded. 
Conclusion
PEPFAR funding remains of critical importance to KP programming in many countries. However, 
disproportionate HIV risk and suboptimal service coverage among KPs underscores the continuing 
importance of prioritizing both KP resources and targeted interventions. Though overall PEPFAR planned KP 
funding has increased in recent years, extreme variability among countries suggests the need for a greater 
system-wide emphasis and closer alignment with HIV epidemiology. This is not a challenge for PEPFAR to 
meet alone. It is imperative that all donors supporting the global AIDS response make stronger commitments 
to those populations that have been historically marginalized and continue to face the greatest risk
KPs also require specifically 
targeted interventions that address 
the social and structural barriers 
they face, including, in most cases, 
significant discrimination, violence 
and criminalization. Reducing 
barriers faced by KPs in accessing 
programs targeting the general 
population, while important, is 
insufficient. All PEPFAR tracking 
and reporting mechanisms should provide sufficient information to understand how resources are being 
allocated. In this regard, PEPFAR should collaborate with civil society advocates to understand how best to 
encourage the appropriate implementation and scale-up of evidence-based programs for KPs. In crafting 
reporting requirements for KP funds, PEPFAR should solicit input from and collaborate with civil society, 
taking into consideration how reporting data will be of most use in supporting community advocacy.
NSPs were among the least frequently funded 
… though such programs are among the most 
effective HIV prevention interventions.
All PEPFAR tracking and reporting mechanisms 
should provide sufficient information to understand 
how resources are being allocated.
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